Covered recipient · General Payments record
RAJASREE AJAY
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$2,302.98
- Reported across 140 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $240.99 | 13 |
| Education | $99.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| SEAGEN INC. | $99.00 | 1 |
| PFIZER INC. | $91.56 | 5 |
| ARRAY BIOPHARMA INC | $22.68 | 1 |
| ADC Therapeutics America, Inc. | $21.59 | 1 |
| Mirati Therapeutics, Inc. | $21.37 | 1 |
| Acerta Pharma LLC | $18.86 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $18.17 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $17.47 | 1 |
| Janssen Biotech, Inc. | $15.50 | 1 |
| Exelixis Inc. | $13.79 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ADC Therapeutics America, Inc. | $21.59 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121191477 | CMS |
| ARRAY BIOPHARMA INC | $22.68 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131356017 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.86 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105867823 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $17.47 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086202332 | CMS |
| Exelixis Inc. | $13.79 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138564138 | CMS |
| Janssen Biotech, Inc. | $15.50 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078381468 | CMS |
| Mirati Therapeutics, Inc. | $21.37 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117167551 | CMS |
| Novartis Pharmaceuticals Corporation | $18.17 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086766609 | CMS |
| PFIZER INC. | $15.49 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131113861 | CMS |
| PFIZER INC. | $18.85 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131314413 | CMS |
| PFIZER INC. | $17.75 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131340367 | CMS |
| PFIZER INC. | $18.62 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131364560 | CMS |
| PFIZER INC. | $20.85 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131393268 | CMS |
| SEAGEN INC. | $99.00 | 11/01/2024 | Education | Undisputed | 01/23/2026 | 1131236851 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.